Final report confirms remdesivir benefits for COVID-19 | National Institutes of Health (NIH)

Final report confirms remdesivir benefits for COVID-19 | National Institutes of Health (NIH): The antiviral drug remdesivir shortened recovery time for patients hospitalized with COVID-19, based on results from the completed trial.